ND4BB New Drugs for Bad Bugs Ongoing | IMI1 | Antimicrobial resistanceInfectious diseasesND4BBClinical trial designConducting clinical trialsClinical networksReal-world data, evidenceDrug discoveryEconomic model
PRIMAVERA Predicting the impact of monoclonal antibodies & vaccines on antimicrobial resistance Ongoing | IMI2 | Antimicrobial resistanceInfectious diseasesVaccinesBiologicalsAMR AcceleratorEconomic model
VALUE-Dx The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use Ongoing | IMI2 | Antimicrobial resistanceRespiratory diseasesInfectious diseasesDiagnosticsEconomic model
